Julio Peguero Rivera, MD
Surgical Critical Care · Santa Isabel, PRNPI 1619969698
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Bard Peripheral Vascular, Inc. accounts for 66.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $2,158 and has fallen 91.4% since, to $185 in 2025.
Across 38 payments — averaging $85.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$2K
- BD$233
- Davol Inc.$131
- Mallinckrodt Hospital Products Inc.$117
- Vifor Pharma, Inc.$100
- Stryker$78
- plus $428 from 11 others
What the payments were for
- Travel & lodging$1,50146%
- Food & beverage$1,61750%
- Education$1133%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 14 | $2,146 |
| BD | 5 | $233 |
| Davol Inc. | 4 | $131 |
| Mallinckrodt Hospital Products Inc. | 2 | $117 |
| Vifor Pharma, Inc. | 1 | $100 |
| Stryker | 1 | $78 |
| Johnson & Johnson | 1 | $68 |
| Calliditas Therapeutics US Inc. | 1 | $60 |
| Medtronic | 1 | $58 |
| Baxter Healthcare | 1 | $55 |
| AstraZeneca | 1 | $48 |
| Travere Therapeutics, Inc. | 1 | $33 |
| Bard Access Systems, Inc. | 1 | $27 |
| Gilead | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Bristol Myers Squibb | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclose Maven Catheter$1,375
How this compares
Too few surgical critical care providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 70 | $730 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 48 | $468 |
| Chlorhexidine Gluconate | 44 | $426 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 43 | $370 |
| Ciprofloxacin Hcl | 47 | $315 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 18 | $223 |
| Levofloxacin | 13 | $120 |
| Tramadol Hcl | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in Santa Isabel
- Guillermo BolanosPonce$39K
- Pablo Rodriguez-OrtizRio Piedras$6K
- Marcos Salgado-CrespoSan Juan$3K
- Nydia de SotoSan Juan$1K
- Mariluz Rivera HernandezSan Juan$428
- Victor Aquino JoseGuayama$127
- Julio Lopez-MaldonadoSan Juan$48
- Yvonne Baerga VarelaSan Juan$26
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.